Cargando…
A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
Increasing evidence has shown that Parkinson’s disease (PD) impairs midbrain dopaminergic, cortical and other neuronal subtypes in large part due to the build-up of lipid- and vesicle-rich α-synuclein (αSyn) cytotoxic inclusions. We previously identified stearoyl-CoA desaturase (SCD) as a potential...
Autores principales: | Nuber, Silke, Chung, Chee Yeun, Tardiff, Daniel F., Bechade, Pascal A., McCaffery, Thomas D., Shimanaka, Kazuma, Choi, Jeonghoon, Chang, Belle, Raja, Waseem, Neves, Esther, Burke, Christopher, Jiang, Xin, Xu, Ping, Khurana, Vikram, Dettmer, Ulf, Fanning, Saranna, Rhodes, Kenneth J., Selkoe, Dennis J., Scannevin, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294123/ https://www.ncbi.nlm.nih.gov/pubmed/35445353 http://dx.doi.org/10.1007/s13311-022-01199-7 |
Ejemplares similares
-
Correction to: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
por: Nuber, Silke, et al.
Publicado: (2022) -
Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
por: Terry-Kantor, Elizabeth, et al.
Publicado: (2020) -
Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease
por: Tardiff, Daniel F., et al.
Publicado: (2022) -
Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase
por: Imberdis, Thibaut, et al.
Publicado: (2019) -
A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice
por: Nuber, Silke, et al.
Publicado: (2020)